I bought recently on the basis that 2RT was worthless, ie there was more than enough value in iTrack to justify a purchase with Novartis withdrawal a catalyst for sentiment change.
These results are positive imo for reasons outlined in the series of tweets linked to my previous post.
Ann: ELX LEAD Clinical trial results, page-12
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.010(3.92%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.5¢ | 26.0¢ | $327.7K | 1.234M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35096 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 22531 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |